PSUSA/00010354/202305 - periodic safety update report single assessment
PSUSA
Human
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Misoprostol (gynaecological indication - termination of pregnancy) : List of nationally authorised medicinal products - PSUSA/00010354/202305
English (EN) (222.33 KB - PDF)
Misoprostol (gynaecological indication - termination of pregnancy) : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00010354/202305
English (EN) (119.51 KB - PDF)
български (BG) (115.81 KB - PDF)
español (ES) (97.41 KB - PDF)
čeština (CS) (154.37 KB - PDF)
dansk (DA) (157.74 KB - PDF)
Deutsch (DE) (109.6 KB - PDF)
eesti keel (ET) (94.15 KB - PDF)
ελληνικά (EL) (134.29 KB - PDF)
français (FR) (114.57 KB - PDF)
hrvatski (HR) (156.74 KB - PDF)
íslenska (IS) (125.37 KB - PDF)
italiano (IT) (224.51 KB - PDF)
latviešu valoda (LV) (167.66 KB - PDF)
lietuvių kalba (LT) (199.65 KB - PDF)
magyar (HU) (128.18 KB - PDF)
Malti (MT) (150.88 KB - PDF)
Nederlands (NL) (234.5 KB - PDF)
norsk (NO) (99.91 KB - PDF)
polski (PL) (134.73 KB - PDF)
português (PT) (92.02 KB - PDF)
română (RO) (120.82 KB - PDF)
slovenčina (SK) (162.43 KB - PDF)
Suomi (FI) (194.89 KB - PDF)
svenska (SV) (194.3 KB - PDF)